169 related articles for article (PubMed ID: 31324951)
1. Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart.
Heinz S; Freyberger A; Lawrenz B; Schladt L; Schmuck G; Ellinger-Ziegelbauer H
Arch Toxicol; 2019 Sep; 93(9):2603-2615. PubMed ID: 31324951
[TBL] [Abstract][Full Text] [Related]
2. Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport.
Velez J; Pan R; Lee JT; Enciso L; Suarez M; Duque JE; Jaramillo D; Lopez C; Morales L; Bornmann W; Konopleva M; Krystal G; Andreeff M; Samudio I
Oncotarget; 2016 Aug; 7(32):51435-51449. PubMed ID: 27283492
[TBL] [Abstract][Full Text] [Related]
3. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gene expression changes induced by biguanides in db/db mice liver.
Heishi M; Hayashi K; Ichihara J; Ishikawa H; Kawamura T; Kanaoka M; Taiji M; Kimura T
J Toxicol Sci; 2008 Aug; 33(3):339-47. PubMed ID: 18670165
[TBL] [Abstract][Full Text] [Related]
5. Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase.
Bridges HR; Sirviö VA; Agip AN; Hirst J
BMC Biol; 2016 Aug; 14():65. PubMed ID: 27506389
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of deactivated mitochondrial complex I by biguanides.
Matsuzaki S; Humphries KM
Biochemistry; 2015 Mar; 54(11):2011-21. PubMed ID: 25719498
[TBL] [Abstract][Full Text] [Related]
7. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs.
Hsu CC; Wu LC; Hsia CY; Yin PH; Chi CW; Yeh TS; Lee HC
Oncol Rep; 2015 Sep; 34(3):1620-8. PubMed ID: 26133123
[TBL] [Abstract][Full Text] [Related]
8. Comparison of potential risks of lactic acidosis induction by biguanides in rats.
Bando K; Ochiai S; Kunimatsu T; Deguchi J; Kimura J; Funabashi H; Seki T
Regul Toxicol Pharmacol; 2010 Oct; 58(1):155-60. PubMed ID: 20488215
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production.
Pecinova A; Drahota Z; Kovalcikova J; Kovarova N; Pecina P; Alan L; Zima M; Houstek J; Mracek T
Oxid Med Cell Longev; 2017; 2017():7038603. PubMed ID: 28874953
[TBL] [Abstract][Full Text] [Related]
10. The effects of metformin compared to the effects of phenformin on the lactate production and the metabolism of isolated parenchymal rat liver cell.
Jalling O; Olsen C
Acta Pharmacol Toxicol (Copenh); 1984 May; 54(5):327-32. PubMed ID: 6431751
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria.
Bridges HR; Jones AJ; Pollak MN; Hirst J
Biochem J; 2014 Sep; 462(3):475-87. PubMed ID: 25017630
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Effects of Metformin, Phenformin, and Inhibitors of Mitochondrial Complex I on Mitochondrial Permeability Transition and Ischemic Brain Injury.
Skemiene K; Rekuviene E; Jekabsone A; Cizas P; Morkuniene R; Borutaite V
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33019635
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic biguanides inhibit hormone-induced intracellular Ca2+ concentration oscillations in rat hepatocytes.
Ubl JJ; Chen S; Stucki JW
Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):561-7. PubMed ID: 7998993
[TBL] [Abstract][Full Text] [Related]
14. Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties.
Drahota Z; Palenickova E; Endlicher R; Milerova M; Brejchova J; Vosahlikova M; Svoboda P; Kazdova L; Kalous M; Cervinkova Z; Cahova M
Physiol Res; 2014; 63(1):1-11. PubMed ID: 24182344
[TBL] [Abstract][Full Text] [Related]
15. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
[TBL] [Abstract][Full Text] [Related]
17. [Animal experimental studies on the mode of action of biguanides. 1. Studies with hypoglycemia-inducing doses of biguanide].
Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
Arzneimittelforschung; 1972 Jul; 22(7):1157-69. PubMed ID: 4678123
[No Abstract] [Full Text] [Related]
18. The Pituitary Gland is a Novel Major Site of Action of Metformin in Non-Human Primates: a Potential Path to Expand and Integrate Its Metabolic Actions.
Vázquez-Borrego MC; Fuentes-Fayos AC; Gahete MD; Castaño JP; Kineman RD; Luque RM
Cell Physiol Biochem; 2018; 49(4):1444-1459. PubMed ID: 30205369
[TBL] [Abstract][Full Text] [Related]
19. Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition.
Piel S; Ehinger JK; Elmér E; Hansson MJ
Acta Physiol (Oxf); 2015 Jan; 213(1):171-80. PubMed ID: 24801139
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin.
Rajeshkumar NV; Yabuuchi S; Pai SG; De Oliveira E; Kamphorst JJ; Rabinowitz JD; Tejero H; Al-Shahrour F; Hidalgo M; Maitra A; Dang CV
Clin Cancer Res; 2017 Sep; 23(18):5639-5647. PubMed ID: 28611197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
